EMD Seminar Series: Abhishek Pandey "Modeling Policy, Measuring Impact: From Coverage Loss to Costly Drugs "

Healthcare policy decisions in the United States have wide-ranging consequences for both population health and economic cost. In this talk, I will discuss recent work from CIDMA that illustrates how quantitative modeling can provide timely evidence for national policy deliberations. We evaluated the “One Big Beautiful Bill” which introduced Medicaid work requirements and coverage reductions, by projecting state-level mortality and morbidity to quantify the health burden of coverage loss. Beyond coverage loss, we also investigated the health impact of expanding access to novel GLP-1 medications, results that were later cited in congressional hearings. Building on this work, we conducted a broader analysis of pharmaceutical pricing, comparing U.S. expenditures with those of five other high-income countries to quantify potential national savings under international reference pricing. Together, our research highlights how modeling can provide timely, policy-relevant evidence at the intersection of health and economics.

YSPH values inclusion and access for all participants

If you have questions about accessibility or would like to request an accommodation, please contact Christina Ciarleglio at christina.ciarleglio@yale.edu